The sex difference in haemoglobin levels in adults - Mechanisms, causes, and consequences

Blood Reviews

Volumn 28, Issue 2, 2014, Pages 41-47

  Murphy, William G ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b IRISH BLOOD TRANSFUSION SERVICE   (Ireland)

Author keywords

Androgen; Enalapril; Erythropoiesis; F hraeus effect; Iron; Oestrogen; Phylogeny; Thrombosis

Indexed keywords

ANDROGEN; ANGIOTENSIN II; ENALAPRIL; ERYTHROPOIETIN; ESTRADIOL; ESTROGEN; HEMOGLOBIN; TESTOSTERONE;

ADULT; ANEMIA; ARTERIOLE; BLOOD TRANSFUSION; BLOOD VESSEL DIAMETER; CAPILLARY; CARDIOVASCULAR DISEASE; ERYTHROCYTOSIS; ERYTHROPOIESIS; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; IRON DEFICIENCY; KIDNEY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; THROMBOSIS; VASOCONSTRICTION; VASODILATATION; VENOUS BLOOD; VENULE;

ANDROGEN; ENALAPRIL; ERYTHROPOIESIS; FÅHRAEUS EFFECT; IRON; OESTROGEN; PHYLOGENY; THROMBOSIS;

ADULT; ANIMALS; ERYTHROPOIESIS; FEMALE; HEMOGLOBINS; HUMANS; MALE; SEX FACTORS;

EID: 84896071781     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2013.12.003     Document Type: Article

References (90)

1. Yip R., Johnson C., Dallman P.R. Age-related changes in laboratory values used in the diagnosis of anemia and iron deficiency. Am J Clin Nutr 1984, 39:427-436.
2. Vahlquist B. The cause of the sexual differences in erythrocyte, hemoglobin and serum iron levels in human adults. Blood 1950, 5:874-875.
3. Garn S.M., Smith N.J., Clark D.C. Lifelong differences in hemoglobin levels between Blacks and Whites. J Natl Med Assoc 1975, 67:91-96.
4. Ganji V., Kafai M.R. Hemoglobin and hematocrit values are higher and prevalence of anemia is lower in the post-folic acid fortification period than in the pre-folic acid fortification period in US adults. Am J Clin Nutr 2009, 89:363-371.
5. Tilling L., Hunt J., Jiang B., Sanders T.A., Clapp B., Chowienczyk P. Endothelial function does not relate to haemoglobin or serum erythropoietin concentrations and these do not explain the gender difference in endothelial function in healthy middle-aged men and women. Eur J Clin Invest 2013, 43:225-230.
6. Rege A.B., Brookins J., Fisher J.W. A radioimmunoassay for erythropoietin: serum levels in normal human subjects and patients with hemopoietic disorders. J Lab Clin Med 1982, 100:829-843.
7. Murphy W.G., Tong E., Murphy C. Why do women have similar erythropoietin levels to men but lower hemoglobin levels?. Blood 2010, 116:2861-2862.
8. Howell S., Hoffman K., Bartel L., Schwandt M., Morris J., Fritz J. Normal hematologic and serum clinical chemistry values for captive chimpanzees (Pan troglodytes). Comp Med 2003, 53:413-423.
9. Buchl S.J., Howard B. Hematologic and serum biochemical and electrolyte values in clinically normal domestically bred rhesus monkeys (Macaca mulatta) according to age, sex, and gravidity. Lab Anim Sci 1997, 47:528-533.
10. Sato A., Fairbanks L.A., Lawson T., Lawson G.W. Effects of age and sex on hematologic and serum biochemical values of vervet monkeys (Chlorocebus aethiops sabaeus). Contemp Top Lab Anim Sci 2005, 44:29-34.
11. Xie L., Xu F., Liu S., Ji Y., Zhou Q., Wu Q., et al. Age- and sex-based hematological and biochemical parameters for Macaca fascicularis. PLoS One 2013, 8:e64892.
12. Wirz A., Truppa V., Riviello M.C. Hematological and plasma biochemical values for captive tufted capuchin monkeys (Cebus apella). Am J Primatol 2008, 70:463-472.
13. Harewood W.J., Gillin A., Hennessy A., Armistead J., Horvath J.S., Tiller D.J. Biochemistry and haematology values for the baboon (Papio hamadryas): the effects of sex, growth, development and age. J Med Primatol 1999, 28:19-31.
14. Kane J.D., Steinbach T.J., Sturdivant R.X., Burks R.E. Sex-associated effects on hematologic and serum chemistry analytes in sand rats (Psammomys obesus). J Am Assoc Lab Anim Sci 2012, 51:769-774.
15. Michaelson S.M., Scheer K., Gilt S. The blood of the normal beagle. J Am Vet Med Assoc 1966, 148:532-534.
16. Clark P. Haematology of Australian mammals 2004, Csiro Publishing, Collingwood.
17. Boily F., Beaudoin S., Measures L.N. Hematology and serum chemistry of harp (Phoca groenlandica) and hooded seals (Cystophora cristata) during the breeding season, in the Gulf of St. Lawrence, Canada. J Wildl Dis 2006, 42:115-132.
18. Glomski C.A., Pica A. The avian erythrocyte. Its phylogenetic odyssey 2011, CRC Press, Boca Raton.
19. Harris H.S., Benson S.R., Gilardi K.V., Poppenga R.H., Work T.M., Dutton P.H., et al. Comparative health assessment of Western Pacific leatherback turtles (Dermochelys coriacea) foraging off the coast of California, 2005-2007. J Wildl Dis 2011, 47:321-337.
20. Jelkmann W. Regulation of erythropoietin production. J Physiol 2011, 598:1252-1258.
21. Shahani S., Braga-Basaria M., Maggio M., Basaria S. Androgens and erythropoiesis: past and present. J Endocrinol Invest 2009, 32:704-716.
22. Moriyama Y., Fisher J.W. Effects of testosterone and erythropoietin on erythroid colony formation in human bone marrow cultures. Blood 1975, 45:665-670.
23. Claustres M., Sultan C. Androgen and erythropoiesis: evidence for an androgen receptor in erythroblasts from human bone marrow cultures. Horm Res 1988, 29:17-22.
24. Blobel G.A., Orkin S.H. Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1. Mol Cell Biol 1996, 16:1687-1694.
25. Nathan D.G., Gardner F.H. Effects of large doses of androgen on rodent erythropoiesis and body composition. Blood 1965, 26:411-420.
26. Kennedy B.J., Gilbertsen A.S. Increased erythropoiesis induced by androgenic-hormone therapy. N Engl J Med 1957, 256:719-726.
27. Coviello A.D., Kaplan B., Lakshman K.M., Chen T., Singh A.B., Bhasin S. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab 2008, 93:914-919.
28. Palacios A., Campfield L.A., McClure R.D., Steiner B., Swerdloff R.S. Effect of testosterone enanthate on hematopoiesis in normal men. Fertil Steril 1983, 40:100-104.
29. Jockenhövel F., Vogel E., Reinhardt W., Reinwein D. Effects of various modes of androgen substitution therapy on erythropoiesis. Eur J Med Res 1997, 2:293-298.
30. Dukes P.P., Goldwasser E. Inhibition of erythropoiesis by estrogens. Endocrinology 1961, 69:21-29.
31. Beall C.M., Brittenham G.M., Strohl K.P., Blangero J., Williams-Blangero S., Goldstein M.C., et al. Hemoglobin concentration of high-altitude Tibetans and Bolivian Aymara. Am J Phys Anthropol 1998, 106:385-400.
32. Beall C.M., Goldstein M.C. Hemoglobin concentration of pastoral nomads permanently resident at 4,850-5,450meters in Tibet. Am J Phys Anthropol 1987, 73:433-438.
33. Parisotto R., Wu M., Ashenden M.J., Emslie K.R., Gore C.J., Howe C., et al. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica 2001, 86:128-137.
34. Morkeberg J., Lundby C., Nissen-Lie G., Nielsen T.K., Hemmersbach P., Damsgaard R. Detection of darbepoetin alfa misuse in urine and blood: a preliminary investigation. Med Sci Sports Exerc 2007, 39:1742-1747.
35. Neff M.S., Goldberg J., Slifkin R.F., Eiser A.R., Calamia V., Kaplan M., et al. A comparison of androgens for anemia in patients on hemodialysis. N Engl J Med 1981, 304:871-875.
36. Teruel J.L., Marcen R., Navarro-Antolin J., Aguilera A., Fernandez-Juarez G., Ortuño J. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study. J Am Soc Nephrol 1996, 7:140-144.
37. Shaldon S., Koch K.M., Oppermann F., Patyna W.D., Schoeppe W. Testosterone therapy for anaemia in maintenance dialysis. Br Med J 1971, 3:212-215.
38. Mrug M., Stopka T., Julian B.A., Prchal J.F., Prchal J.T. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest 1997, 100:2310-2314.
39. Donnelly S. Why is erythropoietin made in the kidney? The kidney functions as a critmeter. Am J Kidney Dis 2001, 38:415-425.
40. Ifudu O., Uribarri J., Rajwani I., Vlacich V., Reydel K., Delosreyes G., et al. Gender modulates responsiveness to recombinant erythropoietin. Am J Kidney Dis 2001, 38:518-522.
41. Habif S., Mutaf I., Turgan N., Onur E., Duman C., Ozmen D., et al. Age and gender dependent alterations in the activities of glutathione related enzymes in healthy subjects. Clin Biochem 2001, 34:667-671.
42. Zeltser D., Rogowski O., Berliner S., Mardi T., Justo D., Serov J., et al. Sex differences in the expression of haemorheological determinants in individuals with atherothrombotic risk factors and in apparently healthy people. Heart 2004, 90:277-281.
43. Tepper T., Sluiter W.J., Huisman R.M., de Zeeuw D. Erythrocyte Na+/Li+ countertransport and Na+/K+-2Cl co-transport measurement in essential hypertension: useful diagnostic tools or failure? A meta-analysis of 17years of literature. Clin Sci (Lond) 1998, 95:649-657.
44. Jiao Y., Okumiya T., Saibara T., Tsubosaki E., Matsumura H., Park K., et al. An enzymatic assay for erythrocyte creatine as an index of the erythrocyte life time. Clin Biochem 1998, 31:59-65.
45. Goldsmith H.L., Cokelet G.R., Gaehtgens P. Robin Fåhraeus: evolution of his concepts in cardiovascular physiology. Am J Physiol 1989, 257(3 Pt 2):H1005-H1015.
46. Pries A.R., Ley K., Gaehtgens P. Generalization of the Fahraeus principle for microvessel networks. Am J Physiol 1986, 251(6 Pt 2):H1324-H1332.
47. Pries A.R., Secomb T.W., Gaehtgens P. Structure and hemodynamics of microvascular networks: heterogeneity and correlations. Am J Physiol 1995, 269(5 Pt 2):H1713-H1722.
48. Klitzman B., Duling B.R. Microvascular hematocrit and red cell flow in resting and contracting striated muscle. Am J Physiol 1979, 237:H481-H490.
49. Klitzman B., Johnson P.C. Capillary network geometry and red cell distribution in hamster cremaster muscle. Am J Physiol 1982, 242:H211-H219.
50. Chaplin H., Mollison P.L., Vetter H. The body/venous hematocrit ratio: its constancy over a wide hematocrit range. J Clin Invest 1953, 32:1309-1316.
51. Pearson T.C., Guthrie D.L., Simpson J., Chinn S., Barosi G., Ferrant A., et al. Interpretation of measured red cell mass and plasma volume in adults: expert panel on radionuclides of the International Council for Standardization in Haematology. Br J Haematol 1995, 89:748-756.
52. Karlson K.E., Senn L.Y. Simultaneous determination of red cell mass and plasma volume with cr51 and i131 using a pulse height analyzer. Ann Surg 1963, 158:309-318.
53. Tong E., Murphy W.G., Kinsella A., Darragh E., Woods J., Murphy C., et al. Capillary and venous haemoglobin levels in blood donors: a 42-month study of 36,258 paired samples. Vox Sang 2010, 98:547-553.
54. Cable R.G., Steele W.R., Melmed R.S., Johnson B., Mast A.E., Carey P.M., et al. NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). The difference between fingerstick and venous hemoglobin and hematocrit varies by sex and iron stores. Transfusion 2012, 52:1031-1040.
55. Barreiro F.J.J., Valdecasas Huelin J.M. Radiological studies on the vascular anatomy of the forearm and hand - recent progress. The hand 1981, vol. 1:310-325. WB Saunders, Philadelphia.
56. Sangiorgi S., Manelli A., Congiu T., Bini A., Pilato G., Reguzzoni M., et al. Microvascularization of the human digit as studied by corrosion casting. J Anat 2004, 204:123-131.
57. Lindsey S.H., Carver K.A., Prossnitz E.R., Chappell M.C. Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat. J Cardiovasc Pharmacol 2011, 57:598-603.
58. Ma L., Robinson C.P., Thadani U., Patterson E.J. Effect of 17-beta estradiol in the rabbit: endothelium-dependent and -independent mechanisms of vascular relaxation. Cardiovasc Pharmacol 1997, 30:130-135.
59. Meyer M.R., Prossnitz E.R., Barton M. The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascul Pharmacol 2011, 55:17-25.
60. Nakagawa K., Marji J.S., Schwartzman M.L., Waterman M.R., Capdevila J.H. Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension. Am J Physiol Regul Integr Comp Physiol 2003, 284:R1055-R1062.
61. Wu C.C., Schwartzman M.L. The role of 20-HETE in androgen-mediated hypertension. Prostaglandins Other Lipid Mediat 2011, 96:45-53.
62. Wu C.C., Cheng J., Zhang F.F., Gotlinger K.H., Kelkar M., Zhang Y., et al. Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB kinase. Hypertension 2011, 57:788-794.
63. Wang Y.X., Crofton J.T., Bealer S.L., Share L. Sexual dimorphism in regional blood flow responses to vasopressin in conscious rats. Am J Physiol 1997, 273(3 Pt 2):R1126-R1131.
64. Leshem-Rubinow E., Steinvil A., Zeltser D., Berliner S., Rogowski O., Raz R., et al. Association of angiotensin-converting enzyme inhibitor therapy initiation with a reduction in hemoglobin levels in patients without renal failure. Mayo Clin Proc 2012, 87:1189-1195.
65. Pratt M.C., Lewis-Barned N.J., Walker R.J., Bailey R.R., Shand B.I., Livesey J. Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers. Br J Clin Pharmacol 1992, 34:363-365.
66. Song J., Kost C.K., Martin D.S. Androgens potentiate renal vascular responses to angiotensin II via amplification of the Rho kinase signaling pathway. Cardiovasc Res 2006, 72:456-463.
67. Spence R.K., Carson J.A., Poses R., McCoy S., Pello M., Alexander J., et al. Elective surgery without transfusion: influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg 1990, 159:320-324.
68. Lackritz E.M., Campbell C.C., Ruebush T.K., Hightower A.W., Wakube W., Steketee R.W., et al. Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet 1992, 340:524-528.
69. Hawkey C.M., Bennett P.M., Gascoyne S.C., Hart M.G., Kirkwood J.K. Erythrocyte size, number and haemoglobin content in vertebrates. Br J Haematol 1991, 77:392-397.
70. Villolobos M., Leon P., Sessions S.K., Kezer J. Enucleated erythrocytes in plethodontid salamanders. Herpetologica 1988, 44:243-250.
71. Anderson F.A., Spencer F.A. Risk factors for venous thromboembolism. Circulation 2003, 107(23 Suppl. 1):I9-I16.
72. Eischer L., Tscholl V., Heinze G., Traby L., Kyrle P.A., Eichinger S. Hematocrit and the risk of recurrent venous thrombosis: a prospective cohort study. PLoS One 2012, 7:e38705.
73. Toss F., Nordström A., Nordström P. Association between hematocrit in late adolescence and subsequent myocardial infarction in Swedish men. Int J Cardiol 2013, 168:3588-3593.
74. Danesh J., Collins R., Peto R., Lowe G.D. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 2000, 21:515-520.
75. Pearson T.C. Rheology of the absolute polycythaemias. Baillieres Clin Haematol 1987, 1:637-664.
76. Spivak J.L. Erythropoietin use and abuse: when physiology and pharmacology collide. Adv Exp Med Biol 2001, 502:207-224.
77. Horiguchi H., Oguma E., Kayama F. The effects of iron deficiency on estradiol-induced suppression of erythropoietin induction in rats: implications of pregnancy-related anemia. Blood 2005, 106:67-74.
78. Mukundan H., Resta T.C., Kanagy N.L. 17Beta-estradiol decreases hypoxic induction of erythropoietin gene expression. Am J Physiol Regul Integr Comp Physiol 2002, 283:R496-R504.
79. Cole J., Ertoy D., Lin H., Sutliff R.L., Ezan E., Guyene T.T., et al. Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J Clin Invest 2000, 106:1391-1398.
80. Kamper A.L., Nielsen O.J. Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy. Scand J Clin Lab Invest 1990, 50:611-618.
81. Fyhrquist F., Karppinen K., Honkanen T., Saijonmaa O., Rosenlöf K. High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril. J Intern Med 1989, 226:257-260.
82. Gould A.B., Goodman S., DeWolf R., Onesti G., Swartz C. Interrelation of the renin system and erythropoietin in rats. J Lab Clin Med 1980, 96:523-534.
83. Kim-Shapiro D.B., Lee J., Gladwin M.T. Storage lesion: role of red blood cell breakdown. Transfusion 2011, 51:844-851.
84. Raval J.S., Waters J.H., Seltsam A., Scharberg E.A., Richter E., Daly A.R., et al. The use of the mechanical fragility test in evaluating sublethal RBC injury during storage. Vox Sang 2010, 99:325-331.
85. Koch C.G., Li L., Sessler D.I., Figueroa P., Hoeltge G.A., Mihaljevic T., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008, 358:1229-1239.
86. Lelubre C., Vincent J.L. Relationship between red cell storage duration and outcomes in adults receiving red cell transfusions: a systematic review. Crit Care 2013, 17:R66.
87. Douay L. In vitro generation of red blood cells for transfusion: a model for regenerative medicine. Regen Med 2012, 7:1-2.
88. Mountford J., Olivier E., Turner M. Prospects for the manufacture of red cells for transfusion. Br J Haematol 2010, 149:22-34.
89. Yu B., Shahid M., Egorina E.M., Sovershaev M.A., Raher M.J., Lei C., et al. Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier. Anesthesiology 2010, 112:586-594.
90. Natanson C., Kern S.J., Lurie P., Banks S.M., Wolfe S.M. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 2008, 299:2304-2312.